Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment
Tracy M Frech1, Daniel R Machin2, Maureen A Murtaugh2
1University of Utah, Department of Internal Medicine; University of Utah Hospitals and Clinics; and VAMC Salt Lake City, GRECC, Salt Lake City, UT, USA. tracy.frech@hsc.utah.edu.
Insights
Systemic sclerosis digital ulcers lack FDA-approved treatments. This review explores vasodilatory therapies targeting vascular function and endothelial shear stress for prevention and treatment of these ulcers.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Vascular Biology
Background:
- Systemic sclerosis (SSc) patients often develop digital ulcers (DU) due to prolonged ischemia from Raynaud's phenomenon.
- Current treatments for SSc-related DU primarily focus on vasodilation through various pathways.
- There is a lack of FDA-approved drugs specifically for SSc-related DU in the United States.
Purpose of the Study:
- To review vascular tone and endothelial function in SSc.
- To provide a rationale for longitudinal studies on vascular function in SSc patients.
- To support the use of therapeutics targeting endothelial shear stress and vasodilation for DU treatment and prevention.
Main Methods:
- Literature review of existing studies on vascular function in SSc.
- Analysis of therapeutic pathways for vasodilation.
- Discussion of endothelial shear stress as a therapeutic target.
Main Results:
- Vasodilatory medications aim to relax vascular smooth muscle.
- Endothelial dysfunction plays a significant role in SSc vascular complications.
- Targeting endothelial shear stress offers a potential therapeutic avenue.
Conclusions:
- Vasodilatory medications are crucial for managing SSc-related DU.
- Longitudinal studies are needed to understand medication effects on vascular function.
- Access to non-FDA approved vasodilatory medications should be considered for SSc DU treatment.
Abstract:
There are no Federal Drug Administration approved drugs for the treatment of systemic sclerosis vascular digital ulcers (DU) in the United States, which are thought to be an end-stage result of prolonged ischaemia due to severe, prolonged Raynaud's phenomenon. Most therapeutics for vasodilation used in SSc work different pathways to target the smooth muscle to induce vessel relaxation. Longitudinal studies of vascular function allow insight into the effects of medications used for Raynaud's phenomenon in the SSc patient population. In this review, we discuss vascular tone, the function of the endothelium in SSc, and provide the rationale for longitudinal studies of vascular function and therapeutics that target the endothelial shear stress in addition to vasodilation for treatment and prevention of DU. This review provides the rationale for vasodilatory medication use for treatment of SSc-related DU and justifies access to non-FDA approved medications for this indication.
More Related Videos
Related Concept Videos
Shearing Stress
The average shearing stress can be calculated by dividing the shear by the area of the cross-section.
Shearing Stresses in a Beam: Problem Solving
Elastic Strain Energy for Shearing Stresses
Shear Diagram
First, a free-body diagram of the beam is drawn, representing all the external forces and internal reactions acting on the beam. One can calculate the reaction forces at each support by employing the equilibrium equations of force and moment. The vertical component...
Shearing Strain
Normal and Shear Force


